Delayed hypersensitivity challenged by subcutaneous Bemiparin.
M C
MC
Moreno Escobosa
M C
MC
Moya Quesada
S Cruz
SC
Granados
J
J
Amat López
D000284:Administration, Oral; D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects; D003429:Cross Reactions; D004485:Eczema; D017984:Enoxaparin / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D000077425:Fondaparinux; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology / Q000503:physiopathology; D007114:Immunization; D007279:Injections, Subcutaneous; D019637:Orthopedic Procedures; D011134:Polysaccharides / Q000627:therapeutic use; D011183:Postoperative Complications; D011537:Pruritus; D012882:Skin Tests; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control
D000925:Anticoagulants; D017984:Enoxaparin; D006495:Heparin, Low-Molecular-Weight; D011134:Polysaccharides; D000077425:Fondaparinux; C411345:bemiparin